1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States PoC Molecular Diagnostic
Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States PoC Molecular Diagnostic
Market
4. United States PoC Molecular
Diagnostic Market by Technology
4.1. RT -PCR
4.2. INAAT
4.3. Other
5. United States PoC Molecular
Diagnostic Market by Application
5.1. Respiratory Diseases
5.2. Sexually Transmitted Diseases
5.3. Oncology
5.4. Other
6. United States PoC Molecular
Diagnostic Market by End User
6.1. Physician Offices
6.2. Hospital Emergency Departments & Intensive Care Units
6.3. Research Institutes
6.4. Other
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States PoC Molecular Diagnostic
Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States PoC Molecular Diagnostic
Market
4. United States PoC Molecular
Diagnostic Market by Technology
4.1. RT -PCR
4.2. INAAT
4.3. Other
5. United States PoC Molecular
Diagnostic Market by Application
5.1. Respiratory Diseases
5.2. Sexually Transmitted Diseases
5.3. Oncology
5.4. Other
6. United States PoC Molecular
Diagnostic Market by End User
6.1. Physician Offices
6.2. Hospital Emergency Departments & Intensive Care Units
6.3. Research Institutes
6.4. Other
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5